Beverly Rhodes

420 citations
9 papers · 300 indexed · h-index 5
Topics
Hematopoietic Stem Cell Transplantation (5 papers)Neutropenia and Cancer Infections (2 papers)Multiple Myeloma Research and Treatments (2 papers)
Partner nations
United StatesNew Zealand

In The Last Decade

Beverly Rhodes

8 papers receiving 292 citations

Peers

Beverly Rhodes
Comparison fields: 5 of 61
  • Hematology 187
  • Immunology 99
  • Clinical Psychology 51
  • Oncology 49
  • Genetics 37
Replace Laurie Green with:
Laurie Green Canada
Celia Grosskreutz United States
Kareem Jamani Canada
Anne M. Hall United States
Tiffany Lin United States
W Miller United States
U M Saarinen-Pihkala Finland
S Spinelli Italy
Tania Nicole Masmas Denmark
Orly R. Klein United States
Beverly Rhodes relative to Laurie Green Canada Laurie Green's profile →
Citations per field
00.5×3.1×
Laurie Green · 1×
Citations per year

Countries citing papers authored by Beverly Rhodes

Since Specialization
Citations

This map shows the geographic impact of Beverly Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Rhodes more than expected).

Fields of papers citing papers by Beverly Rhodes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Rhodes. The network helps show where Beverly Rhodes may publish in the future.

Co-authorship network of co-authors of Beverly Rhodes

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly Rhodes. A scholar is included among the top collaborators of Beverly Rhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly Rhodes. Beverly Rhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 0
2 12
3 16
4 1
5 22
6 190
7 1
8 2
9 56

About Beverly Rhodes

Beverly Rhodes is a scholar working on Hematology, Health Information Management and Management of Technology and Innovation, having authored 9 papers that have together received 300 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (5 papers), Neutropenia and Cancer Infections (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (187 citations), Issues, ethics and legal aspects (7 citations) and Transplantation (13 citations). Beverly Rhodes has collaborated with scholars based in United States and New Zealand. Frequent co-authors include Jane Kroger, Paolo Anderlini, Sergio Giralt, Veronica Smith, Chitra Hosing, Marcos de Lima, Issa F. Khouri, Richard E. Champlin, J. Neumann and Yvonne Hsu. Their work appears in journals such as Blood, Transfusion and Child Psychiatry & Human Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026